Latest Breaking News On - Heart failure trial - Page 1 : comparemela.com

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes

SUNNYVALE, Calif., Dec. 18, 2023 BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced.

United statesMiranda petoDavid mcclungPeter altmanDevice agencyMedicaid servicesCardiamp cell therapy programBiocardia incExchange commissionGlobenewswire incCenters for medicareMaryland stem cell research fundMedical device agencyFailure trialChief executiveCell therapy

BioCardia : Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes - Form 8-K -December 18, 2023 at 07:02 am EST

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes SUNNYVALE, Calif. - December.

United statesPeter altmanMiranda petoDavid mcclungDevice agency consultation minutesMedicaid servicesExchange commission onBiocardia incDevice agencyCardiamp cell therapy programMaryland stem cell research fundCenters for medicareBiocardia announces expectedFailure japan approval timeline basedMedical device agency consultationJapan pharmaceutical

BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II

SUNNYVALE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for .

United statesPeter altmanDavid mcclungMiranda petoExchange commission onMedicaid servicesMaryland stem cell research fundBiocardia incCenters for medicareCardiamp cell therapy programFailure trialData safety monitoring boardMinnesota livingHeart failure questionnaireSix minute walk distanceUpcoming milestones

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Noord hollandNoord brabantSouth africaUnited kingdomNew yorkUnited statesNew zealandSchleswig holsteinUttar pradeshFrance generalNordrhein westfalenJammu and kashmirSouth koreaWei mingAndhra pradeshEastern cape

BioCardia Completes Submission of CardiAMP Cell Therapy System in Heart Failure to Japan s Pharmaceutical Medical Device Agency

SUNNYVALE, Calif. , July 05, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment…

United statesPeter altmanDavid mcclungAnne lalucCardiamp cell therapy programNational principal investigatorsCenters for medicareMaryland stem cell research fundEuropean unionBiocardia incDevice agencyExchange commission onMedicaid servicesTherapy systemMedical device agencyHeart failure